Combination strategies have led to improved survival in patients with advanced prostate cancer. Researchers hope to build on this success by implem......READ MORE
Prostate-specific membrane antigen positron emission tomography (PSMA PET) continues to be widely adopted. Clinical trials including both PSMA PET ......READ MORE
The US Food and Drug Administration (FDA) recently approved a targeted radioligand therapy for use in previously treated patients with prostate-spe......READ MORE
Our featured expert discusses emerging noninvasive tools for advanced prostate cancer. These include circulating tumor DNA (ctDNA) assays and prost......READ MORE
The standards of care in advanced prostate cancer reflect the importance of optimizing cancer treatments in view of their efficacy and the complica......READ MORE
